Unusual reactivity in a commercial chromium supplement compared to baseline DNA cleavage with synthetic chromium complexes

被引:27
作者
Chaudhary, S
Pinkston, J
Rabile, MM
Van Horn, JD
机构
[1] Univ Missouri, Dept Chem, Kansas City, MO 64110 USA
[2] Univ Missouri, Dept Chem, Columbia, MO 65211 USA
关键词
chromium(III) complexes; chromium supplements; DNA cleavage; chromium picolinate; chromium bis-histidine;
D O I
10.1016/j.jinorgbio.2004.12.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Commercially available chromium supplements were tested for their DNA cleavage ability compared with synthetic chromium(III) complexes, including chromium(III) tris-picolinate [Cr(pic)(3)], basic chromium acetate [Cr3O(OAc)(6)](+), model complexes, and recently patented Cr-complexes for use in supplements or therapy. Four different supplements (P1-P4) were tested for their DNA cleaving activity in the presence and the absence of H2O2, dithiothreitol (DTT) or ascorbate. One supplement, P1, showed nicking of DNA in the absence of oxidant or reductant at 120 muM metal concentration. Different lot numbers of P1 were also tested for DNA cleavage activity with similar results. Commercial supplements containing Cr(pic)(3) nicked DNA at greater than or equal to 120 muM metal concentrations in the presence of 5 mM ascorbate or with excess hydrogen peroxide, analogous to reactions with synthetic Cr(pic)(3) reported elsewhere. Another chromium (non-Cr(pic)(3)) supplement, P2, behaves in a comparable manner to simple Cr(III) salts in the DNA nicking assay. Chromium(III) malonate [Cr(mal)(2)] and chromium(III) acetate [Cr(OAc)] can nick DNA in the presence of ascorbate or hydrogen peroxide, respectively, only at higher metal concentrations. The Cr(III) complexes of histidine, succinate or N-acetyl-L-glutamate do not nick DNA to a significant degree. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:787 / 794
页数:8
相关论文
共 42 条
[1]   Chromium, glucose intolerance and diabetes [J].
Anderson, RA .
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1998, 17 (06) :548-555
[2]  
Anderson RA, 2004, United States Patent, Patent No. [US 6,689,383 B1, 6689383]
[3]   CHROMIUM(III) AND THE GLUCOSE-TOLERANCE FACTOR [J].
BARRETT, J ;
OBRIEN, P ;
DEJESUS, JP .
POLYHEDRON, 1985, 4 (01) :1-14
[5]   Studies on the genotoxicity of chromium: from the test tube to the cell [J].
Codd, R ;
Dillon, CT ;
Levina, A ;
Lay, PA .
COORDINATION CHEMISTRY REVIEWS, 2001, 216 :537-582
[6]  
*COMM AN NUTR BOAR, 1997, ROL CHROM AN NUTR
[7]   CHROMIUM(III) COMPLEXES AND THEIR RELATIONSHIP TO THE GLUCOSE-TOLERANCE FACTOR .2. STRUCTURE AND BIOLOGICAL-ACTIVITY OF AMINO-ACID COMPLEXES [J].
COOPER, JA ;
BLACKWELL, LF ;
BUCKLEY, PD .
INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1984, 92 (01) :23-31
[8]   CHEMISTRY OF POLYNUCLEAR COMPOUNDS .6. MAGNETIC PROPERTIES OF TRIMERIC CHROMIUM AND IRON CARBOXYLATES [J].
EARNSHAW, A ;
FIGGIS, BN ;
LEWIS, J .
JOURNAL OF THE CHEMICAL SOCIETY A -INORGANIC PHYSICAL THEORETICAL, 1966, (12) :1656-&
[9]   Polynuclear chromium(III) carboxlylates Part 2. Chromium(III) acetate - what's in it? [J].
Eshel, M ;
Bino, A .
INORGANICA CHIMICA ACTA, 2001, 320 (1-2) :127-132
[10]   CHROMIUM PICOLINATE INCREASES MEMBRANE FLUIDITY AND RATE OF INSULIN INTERNALIZATION [J].
EVANS, GW ;
BOWMAN, TD .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1992, 46 (04) :243-250